Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

15.53
+0.11000.71%
Post-market: 15.530.00000.00%19:30 EDT
Volume:3.29M
Turnover:51.08M
Market Cap:3.13B
PE:-18.79
High:15.62
Open:15.62
Low:15.39
Close:15.42
52wk High:16.20
52wk Low:9.84
Shares:201.40M
Float Shares:195.63M
Volume Ratio:0.94
T/O Rate:1.68%
Dividend:1
Dividend Rate:6.44%
EPS(TTM):-0.8265
EPS(LYR):-1.4300
ROE:-4.86%
ROA:2.75%
PB:1.01
PE(LYR):-10.86

Loading ...

Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium

GlobeNewswire
·
Sep 10

First Infant Data from Ascendis Trial of Once-Weekly TransCon CNP (Navepegritide) Presented at ESPE 2026

GlobeNewswire
·
Sep 10

Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027

GlobeNewswire
·
Sep 09

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

GlobeNewswire
·
Sep 09

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

Park Hotels & Resorts Price Target Raised to $18.00/Share from $14.00 by BMO Capital

Dow Jones
·
Sep 01

U.S. Stocks on the MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics

Reuters
·
Sep 01

Park Hotels & Resorts Inc : Bmo Raises to Outperform from Market Perform; Raises Target Price to $18 from $14

THOMSON REUTERS
·
Sep 01

BMO Capital Upgrades Park Hotels & Resorts to Outperform From Market Perform, Adjusts PT to $18 From $14

MT Newswires Live
·
Sep 01

Is Park Hotels & Resorts (PK) A Bargain As Its Share Price Run Raises Valuation Questions?

Simply Wall St.
·
Aug 30

Park Hotels & Resorts is Maintained at Equal-Weight by Barclays

Dow Jones
·
Aug 27

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

GlobeNewswire
·
Aug 25

Morgan Stanley Remains a Hold on Park Hotels & Resorts (PK)

TIPRANKS
·
Aug 25

Top Economist Guan Tao Joins Huafu Securities, Igniting a High-Stakes Research Rivalry Between Fujian's Two Brokerage Giants

Deep News
·
Aug 21

Why Park Hotels & Resorts (PK) Is Up 6.6% After Returning To Profitability In Q2 2026

Simply Wall St.
·
Aug 20

Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP

GlobeNewswire
·
Aug 18

Park Hotels & Resorts (PK) Returns To Profit, Is The 22% Undervalued View Still Compelling?

Simply Wall St.
·
Aug 17

Inflation and Taxes are Eating into Your Savings. What You Can Do About It.

Dow Jones
·
Aug 14

Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 13

Press Release: Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results

Dow Jones
·
Aug 12